Evidence map›Paper›PMID 34727899›Full record

ArticleBMC endocrine disorders2021

Is diabetic ketoacidosis a good predictor of 5-year metabolic control in children with newly diagnosed type 1 diabetes?

Kowalczyk Emilia, Stypułkowska Aneta, Majewska Barbara, Jarzębowska Małgorzata, Hoffmann Aleksandra, Buła Paulina, Szypowska Agnieszka

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC endocrine disorders, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kowalczyk EmiliaDepartment of Pediatric Diabetology and Pediatrics, Pediatric Teaching Clinical Hospital of the Medical University of Warsaw, Żwirki i Wigury 63A, 02-091, Warsaw, Poland. emilia.kowalczyk@uckwum.pl.
Stypułkowska AnetaDepartment of Pediatric Diabetology and Pediatrics, Pediatric Teaching Clinical Hospital of the Medical University of Warsaw, Żwirki i Wigury 63A, 02-091, Warsaw, Poland.
Majewska BarbaraStudents' Scientific Association, Medical University of Warsaw, Warsaw, Poland.
Jarzębowska MałgorzataStudents' Scientific Association, Medical University of Warsaw, Warsaw, Poland.
Hoffmann AleksandraStudents' Scientific Association, Medical University of Warsaw, Warsaw, Poland.
Buła PaulinaStudents' Scientific Association, Medical University of Warsaw, Warsaw, Poland.
Szypowska AgnieszkaDepartment of Pediatrics, Medical University of Warsaw, Warsaw, Poland.
Medical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe study aimed to evaluate whether the presence of DKA at diabetes diagnosis was associated with poorer metabolic control during a 5-year follow-up.

methodsThe study included children treated due to newly diagnosed T1D complicated with DKA between 2010 and 2014 with a complete 5-year follow-up. In every case we performed individual matching for age, gender and BMI with a person without DKA (nDKA) on recognition. We collected data regarding treatment modality, HbA

results85 children at the median age of 7.93 years had DKA at diabetes diagnosis. The median pH was 7.19.Continuous subcutaneous insulin infusion (CSII) was used in 87% of participants in each group. No differences in HbA

conclusionsThe presence of DKA at diabetes diagnosis is not associated with deteriorated long-term metabolic control in children using modern technologies. The early implementation of CSII into diabetes treatment may change the effect of DKA and lead to a long-term HbA

Indexed as

ChildChild, PreschoolDiabetes Mellitus, Type 1Diabetic KetoacidosisFemaleFollow-Up StudiesGlycated HemoglobinGlycemic ControlHumansHypoglycemic AgentsInfusion Pumps, ImplantableInsulinInsulin Infusion SystemsMalePrognosisSeverity of Illness IndexGlycated Hemoglobinhemoglobin A1c protein, humanHypoglycemic AgentsInsulinChildren and adolescentsDevicesIn-patient diabetesOther complicationsSelf-management

Identifiers

PMID34727899
PMCPMC8561920
OpenAlexW3179138929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.